Session Datesort ascending
Why Metabolic Alterations are Key to Hepatocellular Carcinoma 09/23/2019 - 12:00pm to 1:00pm
Fine-tuning Immunotherapy in MMR-D/MSI-H Colorectal Cancer Patients 09/16/2019 - 12:00pm to 1:00pm
Tumor-Specific Mitochondrial DNA Variants as Biomarkers in Head and Neck Malignancies 09/09/2019 - 12:00pm to 1:00pm
Co-Clinical Trials Targeting DNA Repair and Oncogenic Signaling Pathways to Enhance Responsiveness to Cancer Immunotherapy 08/26/2019 - 12:00pm to 1:00pm
Using Clinical and Genomic Risk to Personalize Adjuvant Therapy in Breast Cancer and Communicating Prognosis to Patients with Advanced Cancer 08/19/2019 - 12:00pm to 1:00pm
Practical Bayesian Adaptive Designs for Clinical Trials 08/12/2019 - 12:00pm to 1:00pm
Faculty Development: Evaluation of Trainees and Best Practices for Feedback 08/05/2019 - 12:00pm to 1:00pm
Knowing When To Stop: How Does Immunotherapy Treatment Duration Impact Overall Response? and Behavioral Economics in Oncology 07/29/2019 - 12:00pm to 1:00pm
“Non-Cytotoxic Epigenetic Drugs to Terminate Cancer but Not Normal Self-Replication” 07/22/2019 - 12:00pm to 1:00pm
“Psychological Distress in Adolescents and Young Adults (AYAs) with Cancer” 07/15/2019 - 12:00pm to 1:00pm

Pages